NCT05851768 Efficacy of Dexmedetomidine VS Magnesium Sulphate With Bupivacaine in Erector Spinae Block for Thoracotomy Pain
| NCT ID | NCT05851768 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute, Egypt |
| Condition | Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-05-15 |
| Primary Completion | 2026-11-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-05-15 with a primary completion date of 2026-11-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Postoperative pain management is considered an integral part of perioperative care in patients undergoing thoracotomy. In order to reduce these complications, multiple regional techniques have been developed for thoracotomy including Intercostal nerve block, Erectospinae plane block and serratus block. Multiple adjuvants have been used in regional analgesia including adrenaline,clonidine,magnesium sulphate,dexmedatomidine and opoids.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years. * Male and female sexes. * ASA I-II.,III * Cancer patients undergoing thoracotomy incisions * Body mass index (BMI) from 18.5 to 30 kg/m2 Exclusion Criteria: * Patient refusal * Known allergy to any of the used drugs * Low platelet count, any coagulation defect
Contact & Investigator
Walaa Y Elsabeeny, MD
PRINCIPAL INVESTIGATOR
Assistant professor of Anesthesia and Pain Management, National Cancer Institute, Cairo University
Frequently Asked Questions
Who can join the NCT05851768 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05851768 currently recruiting?
Yes, NCT05851768 is actively recruiting participants. Contact the research team at walaa.elsabeeny@nci.cu.edu.eg for enrollment information.
Where is the NCT05851768 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT05851768 clinical trial?
NCT05851768 is sponsored by National Cancer Institute, Egypt. The principal investigator is Walaa Y Elsabeeny, MD at Assistant professor of Anesthesia and Pain Management, National Cancer Institute, Cairo University. The trial plans to enroll 60 participants.